170 related articles for article (PubMed ID: 34710826)
1. Antisense oligonucleotide repress telomerase activity via manipulating alternative splicing or translation.
Zhou J; Li T; Geng X; Sui L; Wang F
Biochem Biophys Res Commun; 2021 Dec; 582():118-124. PubMed ID: 34710826
[TBL] [Abstract][Full Text] [Related]
2. A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells.
Wang F; Cheng Y; Zhang C; Chang G; Geng X
J Neurooncol; 2019 May; 143(1):57-68. PubMed ID: 30887243
[TBL] [Abstract][Full Text] [Related]
3. Regulation of telomerase alternative splicing: a target for chemotherapy.
Wong MS; Chen L; Foster C; Kainthla R; Shay JW; Wright WE
Cell Rep; 2013 Apr; 3(4):1028-35. PubMed ID: 23562158
[TBL] [Abstract][Full Text] [Related]
4. Phosphorothioate‑modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy.
Cao F; Ju X; Chen D; Jiang L; Zhu X; Qing S; Fang F; Shen Y; Jia Z; Zhang H
Mol Med Rep; 2017 Aug; 16(2):2089-2094. PubMed ID: 28627628
[TBL] [Abstract][Full Text] [Related]
5. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
Diala I; Murao S; Fujii M
Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
[TBL] [Abstract][Full Text] [Related]
6. Delivering Antisense Morpholino Oligonucleotides to Target Telomerase Splice Variants in Human Embryonic Stem Cells.
Radan L; Hughes CS; Teichroeb JH; Postovit LM; Betts DH
Methods Mol Biol; 2016; 1341():133-42. PubMed ID: 25822725
[TBL] [Abstract][Full Text] [Related]
7. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
Diala I; Shiohama Y; Fujita T; Kotake Y; Demonacos C; Krstic-Demonacos M; Leva GD; Fujii M
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):407-425. PubMed ID: 32310030
[TBL] [Abstract][Full Text] [Related]
11. Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.
Brambilla C; Folini M; Gandellini P; Daprai L; Daidone MG; Zaffaroni N
Cell Mol Life Sci; 2004 Jul; 61(14):1764-74. PubMed ID: 15241552
[TBL] [Abstract][Full Text] [Related]
12. [Telomerase gene antisense oligodeoxynucleotide down-regulates telomerase activity in HL-60 cells].
He DM; Zhang H
Ai Zheng; 2002 Oct; 21(10):1070-4. PubMed ID: 12508645
[TBL] [Abstract][Full Text] [Related]
13. Visualizing the down-regulation of hTERT mRNA expression using gold-nanoflare probes and verifying the correlation with cancer cell apoptosis.
Sun H; Hong M; Yang Q; Li C; Zhang G; Yue Q; Ma Y; Li X; Li CZ
Analyst; 2019 May; 144(9):2994-3004. PubMed ID: 30892312
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Gao XD; Chen YR
Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
[TBL] [Abstract][Full Text] [Related]
16. RNA therapeutics: beyond RNA interference and antisense oligonucleotides.
Kole R; Krainer AR; Altman S
Nat Rev Drug Discov; 2012 Jan; 11(2):125-40. PubMed ID: 22262036
[TBL] [Abstract][Full Text] [Related]
17. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
Gao XD; Chen YR
Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489
[TBL] [Abstract][Full Text] [Related]
19. [Effect of tankyrase antisense oligonucleotide combined human telomerase reverse transcriptase antisense oligonucleotide on telomere dynamics in human lung adenocarcinoma A549 cells].
Lu HD; Huang T; Shen WZ; Zhen Y; Kong QZ
Ai Zheng; 2007 Nov; 26(11):1164-9. PubMed ID: 17991312
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
